NTRBW
Nutriband Inc.
Nutriband Inc. (NTRBW) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 27.8 (oversold), with 0/3 trend checks passing.
NTRBW with MA50 and MA200
Key levels & signals
Nutriband Inc. (NTRBW) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $0.61, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 43.4% and below the 200-day moving average by 58.1%.
NTRBW currently has an RSI reading of 27.8, which suggests weaker momentum and a more oversold condition. Some traders may review this kind of setup for a rebound or buy-the-dip idea, but oversold readings by themselves do not guarantee a reversal.
For traders reviewing NTRBW next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.
About Nutriband Inc.
Nutriband Inc. is a pharmaceutical company dedicated to advancing a diverse pipeline of transdermal drug products. Foremost among its developmental initiatives is an abuse-deterrent fentanyl transdermal system. This innovative patch aims to provide both healthcare providers and patients with an extended-release fentanyl solution for the effective management of chronic pain. Beyond its core transdermal portfolio, Nutriband Inc. also holds a licensing agreement with Rambam Med-Tech Ltd. for the development of RAMBAM Closed System Transfer Devices. Established in 2016, the company maintains its corporate headquarters in Orlando, Florida.
NTRBW shares outstanding over time
Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.
Learn the indicators behind this page
More stock opportunities
Common questions about NTRBW
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.